These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 29415500)

  • 1. Impact, Characterization, and Rescue of Pre-mRNA Splicing Mutations in Lysosomal Storage Disorders.
    Dardis A; Buratti E
    Genes (Basel); 2018 Feb; 9(2):. PubMed ID: 29415500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splicing Modulation as a Promising Therapeutic Strategy for Lysosomal Storage Disorders: The Mucopolysaccharidoses Example.
    Santos JI; Gonçalves M; Matos L; Moreira L; Carvalho S; Prata MJ; Coutinho MF; Alves S
    Life (Basel); 2022 Apr; 12(5):. PubMed ID: 35629276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an Antisense Oligonucleotide-Mediated Exon Skipping Therapeutic Strategy for Mucolipidosis II: Validation at RNA Level.
    Matos L; Vilela R; Rocha M; Santos JI; Coutinho MF; Gaspar P; Prata MJ; Alves S
    Hum Gene Ther; 2020 Jul; 31(13-14):775-783. PubMed ID: 32283951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary biochemical and morphological consequences in lysosomal storage diseases.
    Alroy J; Garganta C; Wiederschain G
    Biochemistry (Mosc); 2014 Jul; 79(7):619-36. PubMed ID: 25108325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From bedside to cell biology: a century of history on lysosomal dysfunction.
    Coutinho MF; Matos L; Alves S
    Gene; 2015 Jan; 555(1):50-8. PubMed ID: 25275857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocytes and lysosomal storage diseases.
    Rama Rao KV; Kielian T
    Neuroscience; 2016 May; 323():195-206. PubMed ID: 26037807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial Dysfunction and Neurodegeneration in Lysosomal Storage Disorders.
    Plotegher N; Duchen MR
    Trends Mol Med; 2017 Feb; 23(2):116-134. PubMed ID: 28111024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for lysosomal storage diseases: progress, challenges and future prospects.
    Seregin SS; Amalfitano A
    Curr Pharm Des; 2011; 17(24):2558-74. PubMed ID: 21774776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lysosomal storage diseases--an overview].
    Kloska A; Tylki-Szymańska A; Wegrzyn G
    Postepy Biochem; 2011; 57(2):128-32. PubMed ID: 21913413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene transfer strategies for correction of lysosomal storage disorders.
    D'Azzo A
    Acta Haematol; 2003; 110(2-3):71-85. PubMed ID: 14583667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New strategies for the treatment of lysosomal storage diseases (review).
    Parenti G; Pignata C; Vajro P; Salerno M
    Int J Mol Med; 2013 Jan; 31(1):11-20. PubMed ID: 23165354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TFEB regulates lysosomal proteostasis.
    Song W; Wang F; Savini M; Ake A; di Ronza A; Sardiello M; Segatori L
    Hum Mol Genet; 2013 May; 22(10):1994-2009. PubMed ID: 23393155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical Chaperones and Proteostasis Regulators in the Therapy of Lysosomal Storage Disorders: Current Perspective and Future Promises.
    Mohamed FE; Al-Gazali L; Al-Jasmi F; Ali BR
    Front Pharmacol; 2017; 8():448. PubMed ID: 28736525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lysosomes and lysosomal storage diseases].
    Germain DP
    J Soc Biol; 2002; 196(2):127-34. PubMed ID: 12360741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysosomal exocytosis and lipid storage disorders.
    Samie MA; Xu H
    J Lipid Res; 2014 Jun; 55(6):995-1009. PubMed ID: 24668941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysosomal storage diseases: Stem cell-based cell- and gene-therapy.
    Kim SU
    Cell Transplant; 2014 May; ():. PubMed ID: 24853878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current molecular genetics strategies for the diagnosis of lysosomal storage disorders.
    Giugliani R; Brusius-Facchin AC; Pasqualim G; Leistner-Segal S; Riegel M; Matte U
    Expert Rev Mol Diagn; 2016; 16(1):113-23. PubMed ID: 26567866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BK channel agonist represents a potential therapeutic approach for lysosomal storage diseases.
    Zhong XZ; Sun X; Cao Q; Dong G; Schiffmann R; Dong XP
    Sci Rep; 2016 Sep; 6():33684. PubMed ID: 27670435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparative Study on the Alterations of Endocytic Pathways in Multiple Lysosomal Storage Disorders.
    Rappaport J; Manthe RL; Solomon M; Garnacho C; Muro S
    Mol Pharm; 2016 Feb; 13(2):357-368. PubMed ID: 26702793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination Therapies for Lysosomal Storage Diseases: A Complex Answer to a Simple Problem.
    Macauley SL
    Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1(Suppl 1):639-48. PubMed ID: 27491211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.